MedTech’s leaders across Asia-Pacific have 15 confirmed challenges — each addressing between US$1.5bn and US$3.8bn a year — and they’re looking beyond their own industry for the solvers. Amplifai, in collaboration with APACMed, puts selected Innovators in front of the decision-makers: scoped pilots, warm introductions, and the MedTech Forum stage from 2027.
Cohort selection is closed for the current cycle · MedTech Forum showcase from 2027
companies already vetted onto the bench — you’d be joining proven company
raised collectively by the current bench
priced challenges we recruit against — each mapped to real buyer demand
stage formats from 2027: plenary, showcases, pitch finals
Pilot-to-Procurement playbooks
Country-by-country: evidence, reimbursement, tender. The program’s job isn’t a demo day; it’s graduating you into MedTech supply chains and portfolios.
Advisory modules that move the needle
Regulatory pathway mapping, market access & HEOR, GTM playbooks, deal structuring, talent sourcing — pick what your APAC expansion actually needs.
Storytelling Studio
Podcast features, decks, white papers and KOL video — visibility engineered for procurement committees and investors, not vanity metrics.
Who we’re looking for
The answer to a MedTech distribution problem may come from industrial e-commerce; equipment uptime from factory predictive-maintenance AI; counterfeit protection from supply-chain traceability. If your solution attacks one of the 15 challenges — whatever industry you built it in — you’re relevant to a buyer here, and we can show you which one, in which market.
Innovativeness
A genuinely differentiated solution to one or more of the 15 challenges.
Traction
Evidence it works: customers, deployments, clinical or commercial results, capital raised.
MNCs, SMEs and startups all qualify; APAC and non-APAC headquartered alike — the current bench is 45/45.
01
Apply
One form: company, stage, sector, market ambitions, deck upload. About 15 minutes. Applications are reviewed on a rolling basis.
02
Screening & grading
Scored on innovativeness and traction against the 15 challenges; shortlist calls follow.
03
Onboard
Challenge-fit brief, module selection, showcase preparation.
04
Show
MedTech Forum from 2027: plenary, showcases, pitch finals.
05
Pilot
Co-Creation Sprints with matched buyer teams; scoped pilots with evidence plans.
06
Graduate
Pilot-to-Procurement playbook execution; Capital Bridge raise support; results on the Outcomes Dashboard — and the next Forum stage.
Applications are reviewed on a rolling basis. Cohort selection is closed for the current cycle; the next selection is for the 2027 showcase.
The bench
Cloud cardiac diagnostics · Singapore
Minutes-fast AI ECG diagnosis in rural clinics
A cloud ECG platform delivering AI diagnosis in minutes to rural clinics across 16+ countries — backed by leading global corporate venture funds.
Radiology & pathology AI · Australia
Clinical AI live in 1,000+ facilities
Radiology and pathology AI deployed in more than 1,000 facilities, with one of the broadest TGA/CE/FDA clearance portfolios in medical AI; US$240M raised.
Circular economy platform · India
EPR compliance turned into a marketplace
A circular-economy marketplace and EPR compliance platform helping manufacturers meet India’s plastic-waste rules; US$35M+ raised.
Every bench company is mapped to a challenge with confirmed buyer demand. That’s the difference between a cohort and a queue.
Modular participation
One catalogue of 15 modules — growing to 30 by 2028 — with one price list and audience-specific views. Innovators pick up to five modules per phase; phases run half-yearly (H2 2026 through H2 2028). Eight modules are live in 2026, the remainder join from 2027. MNC participants pay cash; startups and SMEs may combine cash with flexible fee structures, agreed during selection. No prices on this page by design.
Forum Showcase
Capital Bridge
Co-Creation Sprints
Pilot-to-Procurement
Storytelling Studio
ESG-by-Design
Outcomes Dashboard
Innovation Scouts
Regulatory Pathway Mapping
From 2027
Market Access & HEOR
From 2027
GTM Playbooks
From 2027
Digital Marketing & HCP Engagement
From 2027
Talent Sourcing
From 2027
Deal Structuring
From 2027
Diligence Packs
From 2027
Module descriptions, availability and terms are shared during selection. You’ll see full terms before you commit anything.
FAQ
“We’re not in MedTech — why would we join a MedTech program?”
Because the buyers are here and the problems pay. Sixty-two MedTech companies named these fifteen challenges as risks in their own regulatory filings, and the incumbents are explicitly scanning other industries for solutions. APAC MedTech’s 15 challenges each address between US$1.5bn and US$3.8bn a year of the region’s US$117.7bn MedTech spend — a modelled estimate, separate from the filing counts. Amplifai is the matchmaking layer. Read the full method →Read the full method →
“We’re an established company, not a startup.”
You’re in scope. Innovators span MNC business units, SMEs and startups; several bench companies are Series C and beyond.
“What does it cost?”
Participation is modular and phase-based, tailored during selection. You’ll see full terms before you commit anything.
“What are my odds?”
We’re honest about this: stage slots are limited. But grading is criteria-based — innovativeness and traction beat hype — and non-selected applicants stay in the pipeline for pilots and later cohorts.
“Do you take equity?”
Standard participation doesn’t require it; flexible fee structures exist for earlier-stage companies and are discussed case by case during selection.
“What happens after the Forum?”
The Forum is the showcase, not the finish line. Pilots, procurement playbooks and Capital Bridge support run year-round across the three-year program.
Questions first? hello@amp-lif-ai.com